Erin Brown

Dr. Erin Brown


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
CTChristina M. Theodorou
Christina M. Theodorou
MNMiriam Nuño
Miriam Nuño
KYKaeli J. Yamashiro
Kaeli J. Yamashiro
EBErin Brown
Erin Brown

1 November 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
CTChristina M. Theodorou
Christina M. Theodorou
ABAlana L. Beres
Alana L. Beres
MNMichelle Nguyen
Michelle Nguyen
SCShannon L. Castle
Shannon L. Castle
CFClaire Faltermeier
Claire Faltermeier
EBErin Brown
Erin Brown

1 April 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
JAJennifer H. Aldrink
Jennifer H. Aldrink
RGRichard D. Glick
Richard D. Glick
RBReto M. Baertschiger
Reto M. Baertschiger
AKAfif N. Kulaylat
Afif N. Kulaylat
TLTimothy B. Lautz
Timothy B. Lautz
PEPeter F. Ehrlich
Peter F. Ehrlich

1 October 2021 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
CTChristina M. Theodorou
Christina M. Theodorou
SSSarah C. Stokes
Sarah C. Stokes
MHMennatalla S. Hegazi
Mennatalla S. Hegazi
EBErin Brown
Erin Brown
PSPayam Saadai
Payam Saadai

1 March 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
JJJordan E Jackson
Jordan E Jackson
CTChristina M Theodorou
Christina M Theodorou
OVOlivia Vukcevich
Olivia Vukcevich
EBErin Brown
Erin Brown
ABAlana L. Beres
Alana L. Beres
Identifying pediatric patients who may benefit from gastrostomy tube (GT) placement can be challenging. We hypothesized that many GTs would no longer be in use after 6 months. Inpatient GT placements in patients < 18 years old at a tertiary children's hospital from 9/2014 to 2/2020 were included. The primary outcome was GT use <6 months (short-term). Secondary outcomes included age at placement, indication for GT, and operations for GT-related issues. Fifteen percent (22/142) of GTs were used for <6 months post-operatively. The median duration of short-term GT use was 1.6 months (IQR 0.9-3.4 months). Short-term GTs were more likely to be placed in patients with traumatic brain injury (TBI) (18.2% vs. 4.2%, p = 0.03) and adolescents (≥12 years old, 22.7% vs. 4.0%, p = 0.005). Gastrocutaneous fistula closure was required in 33.3% of short-term patients who had their GTs removed (n = 6/18), with median total hospital charges of $29,989 per patient. Fifteen percent of pediatric GTs placed as inpatients were used for <6 months, more commonly among adolescents and in TBI patients. One-third of patients with short-term GTs required gastrocutaneous fistula closure. Adolescents and TBI patients may benefit from consideration of short-term nasogastric tube (NGT) feeds rather than surgical GT placement. III.

1 August 2023 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
EBErin Brown
Erin Brown
AEAbigail J. Engwall-Gill
Abigail J. Engwall-Gill
JAJennifer H. Aldrink
Jennifer H. Aldrink
PEPeter F. Ehrlich
Peter F. Ehrlich
AFAndrea Fawcett
Andrea Fawcett
TLTimothy B. Lautz
Timothy B. Lautz
Nephrogenic rests (NR) may represent precursor lesions for Wilms tumor (WT), but their clinical course is not fully understood and no guidelines for treatment exist. This study sought to evaluate the outcomes of pediatric patients with NRs related to traditional chemotherapy and surgery. A PRISMA-P-compliant literature search was conducted in MEDLINE, Embase, CINAHL, Web of Science, COCHRANE, and SCOPUS from inception to June 2021. Clinical questions regarding the treatment of NRs, including chemotherapy and surgery, were developed in the population, intervention, comparison, and outcome format. Twenty-five studies including 1445 patients met inclusion criteria for evaluating chemotherapy compared to observation for NRs. Eighteen studies including 1392 patients met inclusion criteria for evaluating the role of surgery for NRs. Patients with isolated NRs who underwent observation progressed to WT 33% of the time; chemotherapy reduced the rate of WT to 3.9%. Observation of multiple NRs and diffuse hyperplastic perilobar nephroblastomatosis (DHPLN) led to progression to WT 50% and 100% of the time, respectively. Chemotherapy reduced the rate of WT to 34% for multiple NRs and 46% for DHPLN. Surgery for isolated NRs reduced the risk of WT development from 23.7% in patients with incomplete excision to 3.3% with complete excision; however, 96% of patients with incompletely excised NRs had bilateral disease. Observation with close surveillance for isolated NRs is safe. Treatment with chemotherapy is recommended for patients with multiple NRs and DHPLN. Surgical management of NRs should focus on renal function preservation. Treatment study, Level III.